Novavax, Inc. Message Board

Search
Current Board
All Boards
Advanced Search
  • Subject Message Body
  • Topics Only Topics And Messages
  • flamfurter flamfurter • Mar 3, 2011 11:22 AM Flag

    Analysts

    Does RBC, Oppenheimer, Merriman and Rodman and Renshaw still follow NVAX? anyone Know. Any other analysts or possible upgrades?

    Sort:  Newest  |  Oldest  |  Most Replied Expand all replies
    • rezoom2 rezoom2 • Mar 3, 2011 4:58 PM Flag

      flam.. if you take the time to go to the NVAX site you'll find the six analysts who follow Novavax. At least do your most basic DD if you're interested in this stock. If you're a day trader, please say so.

      rez

    • majaver26 majaver26 • Mar 3, 2011 11:27 AM Flag

      no. they all worked for hedge funds so NVAX got rid of them. The hedge funds will awys be around but they don't have propriety broker to help them out. stock is going to mive in the next few days. That is the way it is after big news event. The large institional mutual funds have to do their research first. Take a few days to a week. I expect a short cover to come soon.

      • 1 Reply to majaver26
      • persistdb1 persistdb1 • Mar 3, 2011 11:39 AM Flag

        Nice post. The big volume selling is about over. Volume today is down noticably compared to last two days. It has been a wild ride. Now share price should stabilize around this area. Gradually accumulation will take place as you stated.

        I still think the longer term price for this stock considering the 180 million from Barda should be at least 4 dollars and that price will go up as phase 123 results come in if they are positive. They should be positive since NVAX has tested their vaccines on well over 4000 people with good results so far.

        The Barda award has materially reduced the risk of owning NVAX. Yet todays price does not seem to reflect that reality. So I strongly believe share price over the next few weeks will rise to over 3 bucks. JMHO.

 
NVAX
2.010.03(+1.52%)9:52 AMEDT